Success Metrics

Clinical Success Rate
97.5%

Based on 269 completed trials

Completion Rate
97%(269/276)
Active Trials
3(1%)
Results Posted
6%(16 trials)
Terminated
7(2%)

Phase Distribution

Ph not_applicable
76
27%
Ph phase_1
68
24%
Ph phase_3
49
17%
Ph phase_2
78
27%
Ph phase_4
13
5%
Ph early_phase_1
1
0%

Phase Distribution

69

Early Stage

78

Mid Stage

62

Late Stage

Phase Distribution285 total trials
Early Phase 1First-in-human
1(0.4%)
Phase 1Safety & dosage
68(23.9%)
Phase 2Efficacy & side effects
78(27.4%)
Phase 3Large-scale testing
49(17.2%)
Phase 4Post-market surveillance
13(4.6%)
N/ANon-phased studies
76(26.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

97.1%

269 of 277 finished

Non-Completion Rate

2.9%

8 ended early

Currently Active

3

trials recruiting

Total Trials

285

all time

Status Distribution
Active(3)
Completed(269)
Terminated(8)
Other(5)

Detailed Status

Completed269
Terminated7
unknown5
Active, not recruiting2
Withdrawn1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
285
Active
3
Success Rate
97.5%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (0.4%)
Phase 168 (23.9%)
Phase 278 (27.4%)
Phase 349 (17.2%)
Phase 413 (4.6%)
N/A76 (26.7%)

Trials by Status

withdrawn10%
recruiting10%
active_not_recruiting21%
unknown52%
terminated72%
completed26994%

Recent Activity

Clinical Trials (285)

Showing 20 of 285 trialsScroll for more
NCT00092222Phase 2

Virotherapy and Natural History Study of KHSV-Associated Multricentric Castleman s Disease With Correlates of Disease Activity

Active Not Recruiting
NCT01419561Phase 2

Natural History Study of the KSHV Inflammatory Cytokine Syndrome (KICS)

Recruiting
NCT02737046Phase 2

Belinostat Therapy With Zidovudine for Adult T-Cell Leukemia-Lymphoma

Completed
NCT02369406Phase 2

Early Infant HIV Treatment in Botswana

Active Not Recruiting
NCT00799864Phase 2

A Study to Evaluate the Pharmacokinetics, Safety, Tolerability, and Antiviral Activity of Rilpivirine (TMC278) in Human Immunodeficiency Virus Infected Adolescents and Children Aged Greater Than or Equal to 6 Years

Completed
NCT02712801Phase 4

Antiretroviral Regime for Viral Eradication in Newborns

Completed
NCT03088410Phase 4

Study of HIV-Infected and Uninfected Pregnant Woman/Child Dyads in Gaborone, Botswana

Completed
NCT00672412Phase 1

Safety and Pharmacokinetic Study of Fixed Dose Combination of Zidovudine, Lamivudine, and Nevirapine in HIV-Infected Children in Thailand

Completed
NCT00109590Phase 2

Reducing the Incidence of Nevirapine Resistance Mutations in Pregnant HIV Infected Women Who Receive Anti-HIV Drugs Prior to and After Giving Birth

Completed
NCT00001022Phase 3

A Comparison of Zidovudine (AZT) Used Alone or in Combination With Didanosine (ddI) or Dideoxycytidine (ddC) in HIV-Infected Patients

Completed
NCT00001063Phase 2

The Effectiveness of Three Drug Combinations in HIV-Infected Patients Who Have Taken Zidovudine for More Than 12 Weeks

Completed
NCT00000973Phase 1

A Study of Pyrimethamine in the Treatment of Infection by a Certain Parasite in HIV-Positive Patients

Completed
NCT00001095Phase 2

A Study of Three Anti-HIV Drug Combinations in Patients Who Have Taken Amprenavir

Completed
NCT00001001Not Applicable

A Study of Zidovudine in HIV-Infected Patients With Liver Disease

Completed
NCT00000872Phase 2

Treatment With Combinations of Several Antiviral Drugs in Infants and Young Children With HIV Infection

Completed
NCT00000831Phase 2

Virologic Responses To New Nucleoside Regimens After Prolonged ZDV or ddI Monotherapy

Completed
NCT00000810Phase 1

Randomized, Phase I/II, Dose-Ranging, Open-Label Trial of the Anti-HIV Activity of Delavirdine Mesylate (DLV; U-90,152S)

Completed
NCT00001113Phase 1

A Study of AZT Plus Human Interferon Alpha in the Treatment of AIDS-Related Kaposi's Sarcoma

Completed
NCT00000841Phase 3

A Study of Indinavir Sulfate Plus Zidovudine (AZT) Plus Lamivudine in HIV-Infected Patients Who Have Taken AZT for Six or More Months

Completed
NCT00000989Not Applicable

The Safety and Effectiveness of Ganciclovir Used Alone or in Combination With Granulocyte-Macrophage Colony Stimulating Factor in the Treatment of Cytomegalovirus (CMV) of the Eye in Patients With AIDS

Completed

Drug Details

Intervention Type
DRUG
Total Trials
285